Related Experiment Video
Updated: Nov 19, 2025

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
CSN5 Promotes Carcinogenesis of Thyroid Carcinoma Cells Through ANGPTL2
Peiyi Xie1, Hui Wang2, Jiayu Fang3
1Department of General Surgery, Second Affiliated Hospital of Nanchang University, Nanchang, China.
Abstract:
COP9 signalosome subunit 5 (CSN5) plays a key role in carcinogenesis of multiple cancers and contributes to the stabilization of target proteins through deubiquitylation. However, the underlying role of CSN5 in thyroid carcinoma has not been reported. In this research, our data showed that CSN5 was overexpressed in thyroid carcinoma tissues compared with paracancerous tissues. Furthermore, a series of gain/loss functional assays were performed to demonstrate the role of CSN5 in facilitating thyroid carcinoma cell proliferation and metastasis. Additionally, we found there was a positive correlation between CSN5 and angiopoietin-like protein 2 (ANGPTL2) protein levels in thyroid carcinoma tissues and that CSN5 promoted thyroid carcinoma cell proliferation and metastasis through ANGPTL2. We also identified the underlying mechanism that CSN5 elevated ANGPTL2 protein level by directly binding it, decreasing its ubiquitination and degradation. Overall, our results highlight the significance of CSN5 in promoting thyroid carcinoma carcinogenesis and implicate CSN5 as a promising candidate for thyroid carcinoma treatment.
Insights
COP9 signalosome subunit 5 (CSN5) promotes thyroid cancer growth and spread by stabilizing angiopoietin-like protein 2 (ANGPTL2). This discovery highlights CSN5 as a potential therapeutic target for thyroid carcinoma.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- COP9 signalosome subunit 5 (CSN5) is implicated in various cancers.
- CSN5 stabilizes proteins via deubiquitylation.
- The role of CSN5 in thyroid carcinoma remains uncharacterized.
Purpose of the Study:
- To investigate the role and mechanism of CSN5 in thyroid carcinoma.
- To determine if CSN5 influences thyroid carcinoma cell proliferation and metastasis.
- To explore the relationship between CSN5 and angiopoietin-like protein 2 (ANGPTL2) in thyroid cancer.
Main Methods:
- Quantitative analysis of CSN5 expression in thyroid carcinoma tissues.
- In vitro gain-and-loss functional assays to assess cell proliferation and metastasis.
- Correlation analysis between CSN5 and ANGPTL2 protein levels.
- Mechanism studies involving protein binding, ubiquitination, and degradation assays.
Main Results:
- CSN5 is significantly overexpressed in thyroid carcinoma tissues.
- CSN5 facilitates thyroid carcinoma cell proliferation and metastasis.
- CSN5 positively correlates with ANGPTL2 levels in thyroid carcinoma.
- CSN5 promotes thyroid carcinoma progression by upregulating ANGPTL2 via direct binding and reduced degradation.
Conclusions:
- CSN5 plays a crucial role in promoting thyroid carcinoma development.
- CSN5 enhances thyroid carcinoma cell proliferation and metastasis, partly through ANGPTL2.
- CSN5 represents a potential therapeutic target for thyroid carcinoma treatment.
Related Concept Videos
Mutagenicity and Carcinogenicity
Mitogens and the Cell Cycle
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

